World’s Oldest Man Dies; Harvey Weinstein’s Medical Care; Soccer and Brain Damage
Note that some links may require registration or subscription. Also note that MedPage Today will be closed Thursday and Friday ...
Day: November 27, 2024
Diet Matters in Prostate Cancer, but It’s Complicated
Diet is increasingly seen as a modifiable risk factor in prostate cancer.Recent studies have shown that ultralow-carbohydrate diets, weight loss ...
Microplastics Have Been Found in the Human Brain. Now What?
Microplastics have been found in the lungs, liver, blood, and heart. Now, researchers report they have found the first evidence ...
Eating More Red Meat Could Increase Type 2 Diabetes Risk
The holiday season is upon us, and for many people, meat is the centerpiece of celebratory meals. But eating less ...
Which First-Line Treatments Are Most Cost-Effective?
TOPLINE:For initial treatment of eosinophilic esophagitis (EoE), an elimination diet is the most cost-effective option from a payer perspective and ...
TRK Inhibitor Active in Treatment-Refractory Glioblastoma
HOUSTON -- A fourth of patients with TRK fusion primary central nervous system tumors responded to the TRK inhibitor larotrectinib ...
Ontario ED Staffing Struggles Highlight Chronic Shortfall
Ontario’s physicians are seeking to draw attention to chronic staffing struggles that have caused a rapid increase in temporary closures ...
Paying Forward, Giving Back, and Being All the Better for It
During the peak of the pandemic, “it was so tough on everybody, and two of my co-residents quit,” recalled Todd ...
Canada Approves Novo Nordisk’s Obesity Drug to Reduce Risk Of Non-fatal Heart Attack
(Reuters) - Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart ...
Canada Takes One Health Approach to Antimicrobial Resistance
As the global public health community focuses its attention on the ongoing spread of avian influenza across North America — ...
Semaglutide Rocketing Past Statins as Millions Eligible
About 40% of American adults — some 137 million — are eligible to take the glucagon-like peptide 1 (GLP-1) receptor ...
Researchers Differ on How to Manage Incidental Findings
Disparate views on managing incidental imaging findings made during clinical research — particularly for unclear results — signal a need ...
The Most Promising Treatments for Long COVID
Long COVID is a symptom-driven disease, meaning that with no cure, physicians primarily treat the symptoms their patients are experiencing. ...
Early Tourniquet Use Linked to Improved Pediatric Outcomes
TOPLINE:In children with traumatic hemorrhage, tourniquets placed before the arrival of emergency medical services (EMSs) are associated with decreased initial ...
How ‘Make America Healthy Again’ May Have Found Its Moment
Within days of Donald Trump’s election victory, healthcare entrepreneur Calley Means turned to social media to crowdsource advice.“First 100 days,” ...
Can New Therapies Redefine Psoriasis Management?
"For too long, the management of psoriasis and other immune-mediated inflammatory diseases has suffered from an acceptance that improvement rather ...
Insurance Loss Reduces Postpartum Contraception Access
TOPLINE:Insurance loss more than 2 months after childbirth is associated with 26% lower odds of prescription contraception use, with Hispanic ...
GLP-1 Labels Don’t Reflect Trial Exclusions
About a third of people eligible for glucagon-like peptide 1 receptor agonist (GLP-1 RA) medications for weight loss via the ...
Drug Overdose Deaths Involving Ketamine on the Rise
TOPLINE:Detection rates for ketamine in drug overdose deaths in the United States increased from 0.3% in 2019 to 0.5% in ...
ED Anticoagulation Unchanged Despite Use of Support Tool
TOPLINE:A multipronged intervention in US emergency departments (EDs) has been found to not significantly increase anticoagulation initiation within 30 days ...
